"compound 2"
potent, oral heme-displacing IDO1 inhibitor low predicted human dose (<10 mg QD) from ALIS mass-based binding screen + SBDD ACS Med. Chem. Lett., Jul. 15, 2020 Merck & Co., Boston, MA
Molecules of the Month - July 2020
Molecules of the Month
- A-1331852
- dotinurad (FYU-981)
- X-165
- "compound 38a"
- HTL22562
- "compound 23"
- MGS0274
- LXE408
- "compound 2"
- AB680
- "compound 18"
- ETX0282
- "compound 6g"
- EC2629